GenrAb receives Golden Tickets sponsored by Boehringer Ingelheim & Otsuka Pharmaceutical Company

GenrAb is now the winner of two (2) Golden Ticket awards as a result of international competitions that included well over one hundred (100) high-quality biotech companies. Our first Golden Ticket was sponsored by Boehringer Ingelheim at an event held in Dallas, where we won the Therapeutics Section, while the second Golden Ticket was sponsored by Otsuka Pharma and was held at their Waltham, MA, site. Dr. Benjamin Greenberg (CMO) and Larry Tiffany (CEO) collaborated on these presentations, describing both the AGS platform and scientific rationale for the discovery of our lead antibody therapy (TGM-010). Along with each of these accolades came a year of access to BioLabs lab/desk space @ Pegasus Park, Dallas TX. Since the initial award, the Company has expanded its footprint from a foundational lab to becoming our center for preclinical product development as the Company screens our growing library of >250 potentially therapeutic antibodies.